Adaptive Immune Effector Therapies (T-Cell Therapy) for Resistant, Metastatic, or Recurrent Solid Tumors
WRITTEN BY HITESHI PATEL Through evolutionary processes, tumor cells have developed many mechanisms that aid in evading the detection of the immune system. For instance, tumors can downregulate the number of antigens (a harmful toxin) it produces as well as create an immunosuppressive microenvironment with